Intramyocardial sustained delivery of basic fibroblast growth factor improves angiogenesis and ventricular function in a rat infarct model.
about
Biomaterial technology for tissue engineering applications.Intramyocardial injection of a synthetic hydrogel with delivery of bFGF and IGF1 in a rat model of ischemic cardiomyopathyImproved myocardial perfusion and cardiac function by controlled-release basic fibroblast growth factor using fibrin glue in a canine infarct model.Concise review: injectable biomaterials for the treatment of myocardial infarction and peripheral artery disease: translational challenges and progress.Influence of injectable hyaluronic acid hydrogel degradation behavior on infarction-induced ventricular remodelingExtended and sequential delivery of protein from injectable thermoresponsive hydrogelsMicro- and Nanoparticles for Treating Cardiovascular Disease.Angiogenesis with biomaterial-based drug- and cell-delivery systems.Tunable hydrogel-microsphere composites that modulate local inflammation and collagen bulking.Custom design of the cardiac microenvironment with biomaterials.Minimally invasive cell-seeded biomaterial systems for injectable/epicardial implantation in ischemic heart disease.Treatment with basic fibroblast growth factor-incorporated gelatin hydrogel does not exacerbate mechanical allodynia after spinal cord contusion injury in rats.Localized targeting of biomaterials following myocardial infarction: a foundation to build onMyocardial repair: from salvage to tissue reconstruction.Tunable protein release from acetalated dextran microparticles: a platform for delivery of protein therapeutics to the heart post-MI.Monocytes in heart failure: relationship to a deteriorating immune overreaction or a desperate attempt for tissue repair?Injectable acellular hydrogels for cardiac repair.Strategies for tissue engineering cardiac constructs to affect functional repair following myocardial infarction.Nanomedicine in cardiovascular therapy: recent advancements.Thymosin β4 sustained release from poly(lactide-co-glycolide) microspheres: synthesis and implications for treatment of myocardial ischemia.Advances in growth factor delivery for therapeutic angiogenesis.Strategies for the chemical and biological functionalization of scaffolds for cardiac tissue engineering: a review.Myocardial infarction: stem cell transplantation for cardiac regeneration.Cardiac actions of fibroblast growth factor 23.Effect of bone marrow-derived extracellular matrix on cardiac function after ischemic injuryDelivery of basic fibroblast growth factor with a pH-responsive, injectable hydrogel to improve angiogenesis in infarcted myocardium.Designing Acellular Injectable Biomaterial Therapeutics for Treating Myocardial Infarction and Peripheral Artery Disease.bFGF promotes Sca‑1+ cardiac stem cell migration through activation of the PI3K/Akt pathway.Angiogenic Growth Factors for Coronary Artery Disease: Current Status and Prospects.Novel therapeutic approach for pulmonary emphysema using gelatin microspheres releasing basic fibroblast growth factor in a canine model.
P2860
Q30489070-8DC0E42D-300F-49B2-A84A-BBBB7E9A2688Q30596582-C4C514C1-FC64-4AE8-9259-DB00E182CDAEQ33759629-626D385D-EC53-4AEF-B723-8992D194589AQ34109419-A945E5C2-C92F-4B2F-834A-E341CFDB85DEQ35634564-32FB954D-B36F-4BBD-9514-77F72EEFC35FQ35696724-2ADDF607-F093-4150-9C74-871686DFA803Q35801354-E878422D-C513-4DD7-9410-6BB3DB0F5E31Q35837499-18F6AE21-CD5A-4F5C-BB50-22E966FE350BQ36128346-4A5A75C7-5713-49AF-96CD-56155647CABDQ36186023-9F2C820C-8E79-4F96-B866-7BAE50B4D956Q36477618-AB3538CF-147C-4BFD-A0E0-51544E8FD262Q36679703-700E0D3C-01B8-4E13-95EF-6989519B4280Q37170581-F4E669B9-8BD0-41D8-B810-43A4472D4AFDQ37176440-FA80C840-D3B2-44F8-B3BC-19F52573C2C5Q37542987-D0DEE312-76B6-4DC0-8A19-8AA666B35F95Q37608787-1FAAC554-6AF4-4264-8B09-CA8971B0FED6Q37895182-3648F221-DD7B-4D68-B338-22B963EF4200Q37912067-46D7B773-0742-4441-AB3F-B8CC5DF6823FQ38034812-9E3FA158-938E-489A-BB6B-9F8B4CC4FF8EQ38050840-B3C18844-7CAD-4B82-BDD3-427EA4593004Q38060077-753FFEBB-2C8C-40F6-B903-9A4B88F1C371Q38537491-1BA5EF4A-746D-47D3-A6C4-DEFAD82401F1Q38632039-33BBB5C0-90C9-4584-8D4D-1BBF979AF92EQ38977291-7D5AB35A-382E-4DE3-93A1-989CB2660147Q41763555-D0746CB1-68D5-4291-8F67-A1820FF8F3D9Q42580222-87F36F30-E1F0-41BF-9FF7-5B3620EB92F3Q46813976-76F28B0B-D50D-4E54-949B-11EEA1502101Q47328735-208D8B62-2E77-4BA0-BA60-2D543D6853FFQ48197251-FEEAE4F6-C98B-4054-B9E0-6DCBE3A05076Q53618745-CBA8152E-529C-4AC6-B8E4-86F5B4CD4D48
P2860
Intramyocardial sustained delivery of basic fibroblast growth factor improves angiogenesis and ventricular function in a rat infarct model.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Intramyocardial sustained deli ...... nction in a rat infarct model.
@en
Intramyocardial sustained deli ...... nction in a rat infarct model.
@nl
type
label
Intramyocardial sustained deli ...... nction in a rat infarct model.
@en
Intramyocardial sustained deli ...... nction in a rat infarct model.
@nl
prefLabel
Intramyocardial sustained deli ...... nction in a rat infarct model.
@en
Intramyocardial sustained deli ...... nction in a rat infarct model.
@nl
P2093
P1433
P1476
Intramyocardial sustained deli ...... nction in a rat infarct model.
@en
P2093
Atsushi Iwakura
Kazuaki Kataoka
Keiichi Tambara
Masashi Komeda
Masatoshi Fujita
Yasuhiko Tabata
Yutaka Sakakibara
P2888
P356
10.1007/S10380-002-0686-5
P577
2003-05-01T00:00:00Z